Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30394466 | 1.00 | APP (0.50) | APPL3MBTL1TDP1ATMMAPT | |
| SCHEMBL5955989 | 0.92 | CYP1A1 (0.48) | APPL3MBTL1TDP1ATMMAPT | |
| SCHEMBL1155420 | 0.88 | ESR1 (0.46) | APPL3MBTL1TDP1ATMMAPT | |
| SCHEMBL55761 | 0.87 | APP (0.67) | APPL3MBTL1TDP1ATMMAPT | |
| SCHEMBL29357652 | 0.87 | APP (0.67) | APPL3MBTL1TDP1ATMMAPT | |
| SCHEMBL5955971 | 0.86 | GRM5 (0.42) | APPL3MBTL1TDP1ATMACHE | |
| SCHEMBL5955125 | 0.85 | APP (0.43) | APPL3MBTL1TDP1ATMMAPT | |
| SCHEMBL5955970 | 0.83 | RARB (0.45) | APPL3MBTL1TDP1ATMACHE | |
| SCHEMBL7196394 | 0.82 | APP (0.60) | APPMAPTCYP1A2GRM5CYP1A1 | |
| SCHEMBL14565323 | 0.81 | TSHR (0.45) | ATMMEN1ALDH1A1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351580-B2 | Acene-based transmitter molecules for photon upconversion | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-07-16 | — | — | US | claimed |
| US-20180258111-A1 | Acene-based transmitter molecules for photon upconversion | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-09-13 | — | — | US | claimed |
| US-20070126347-A1 | OLEDS with improved efficiency | EASTMAN KODAK COMPANY | 2007-06-07 | — | — | US | claimed |
| US-7183010-B2 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK CORPORATION (US) | 2007-02-27 | — | — | US | claimed |
| US-7175922-B2 | Aggregate organic light emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY (US) | 2007-02-13 | — | — | US | claimed |
| US-20060141287-A1 | OLEDs with improved operational lifetime | EASTMAN KODAK COMPANY | 2006-06-29 | — | — | US | claimed |
| US-20050106415-A1 | Aggregate organic light emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2005-05-19 | — | — | US | claimed |
| US-20040076853-A1 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2004-04-22 | — | — | US | claimed |
| US-10351580-B2 | Acene-based transmitter molecules for photon upconversion | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-07-16 | — | — | US | disclosed |
| US-20180258111-A1 | Acene-based transmitter molecules for photon upconversion | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-09-13 | — | — | US | disclosed |
| JP-2011213596-A | 9-(4-AMINOPHENYL)-10-(4-AMINOPHENYLETHYNYL)ANTHRACENE, AND METHOD FOR PRODUCING THE SAME | WAKAYAMA SEIKA KOGYO KK | 2011-10-27 | — | — | JP | disclosed |
| US-7504163-B2 | Hole-trapping materials for improved OLED efficiency | EASTMAN KODAK COMPANY (US) | 2009-03-17 | — | — | US | disclosed |
| US-20070126347-A1 | OLEDS with improved efficiency | EASTMAN KODAK COMPANY | 2007-06-07 | — | — | US | disclosed |
| US-7183010-B2 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK CORPORATION (US) | 2007-02-27 | — | — | US | disclosed |
| US-20060141287-A1 | OLEDs with improved operational lifetime | EASTMAN KODAK COMPANY | 2006-06-29 | — | — | US | disclosed |
| US-20060040131-A1 | OLEDs with improved operational lifetime | EASTMAN KODAK COMPANY | 2006-02-23 | — | — | US | disclosed |
| US-20060008672-A1 | Hole-trapping materials for improved OLED efficiency | EASTMAN KODAK COMPANY | 2006-01-12 | — | — | US | disclosed |
| US-20050106415-A1 | Aggregate organic light emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2005-05-19 | — | — | US | disclosed |
| WO-2005040303-A1 | AGGREGATE ORGANIC LIGHT EMITTING DIODE DEVICES | EASTMAN KODAK COMPANY (US) | 2005-05-06 | — | — | WO | disclosed |
| US-20040076853-A1 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180258111-A1 | Acene-based transmitter molecules for photon upconversion | ACE, ACE2, AGTR1 | APP 65/4885L3MBTL1 2867/4885TDP1 1526/4885 |
| US-10351580-B2 | Acene-based transmitter molecules for photon upconversion | ACE, ACE2, AGTR1 | APP 65/4885L3MBTL1 2867/4885TDP1 1526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.